Total Payments
$6,058
2024 Payments
$739.23
Companies
30
Transactions
279
Medicare Patients
18,499
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$4,662 (77.0%)
Travel$1,276 (21.1%)
Education$119.63 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,662 | 270 | 77.0% |
| Travel and Lodging | $1,276 | 5 | 21.1% |
| Education | $119.63 | 4 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,013 | 42 | $0 (2024) |
| Medtronic, Inc. | $639.35 | 41 | $0 (2024) |
| Abbott Laboratories | $507.73 | 17 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $388.93 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $366.94 | 23 | $0 (2024) |
| Medtronic Vascular, Inc. | $327.84 | 21 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $292.14 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $207.00 | 13 | $0 (2023) |
| ABIOMED | $204.58 | 13 | $0 (2024) |
| Philips Electronics North America Corporation | $158.21 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $739.23 | 39 | ABIOMED ($154.53) |
| 2023 | $656.98 | 37 | Boston Scientific Corporation ($151.49) |
| 2022 | $589.30 | 41 | Boston Scientific Corporation ($145.26) |
| 2021 | $732.87 | 39 | Medtronic, Inc. ($320.70) |
| 2020 | $390.61 | 20 | AstraZeneca Pharmaceuticals LP ($120.27) |
| 2019 | $844.84 | 55 | Medtronic Vascular, Inc. ($154.75) |
| 2018 | $1,608 | 18 | BOSTON SCIENTIFIC CORPORATION ($1,464) |
| 2017 | $496.30 | 30 | Novartis Pharmaceuticals Corporation ($75.47) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $13.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Renal Denervation System | ||||||
| 11/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Renal Denervation System | ||||||
| 10/23/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: Renal Denervation System | ||||||
| 10/22/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $2.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.77 | General |
| Category: Cardiovascular | ||||||
| 09/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $13.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $6.99 | General |
| Category: Renal Denervation System | ||||||
| 09/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: General - Therapies_CRM | ||||||
| 09/12/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $9.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: Cardiovascular | ||||||
| 09/05/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Heart Failure | ||||||
| 08/21/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $33.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Renal Denervation System | ||||||
| 08/08/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $10.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.44 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/17/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: Renal Denervation System | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: General - Therapies_CRM | ||||||
| 07/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $10.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $15.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/12/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: Stents | ||||||
| 06/10/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $104.52 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 3,286 | 4,751 | $1.3M | $238,663 |
| 2022 | 33 | 3,546 | 5,687 | $1.4M | $282,265 |
| 2021 | 45 | 5,316 | 8,532 | $1.9M | $372,901 |
| 2020 | 48 | 6,351 | 9,803 | $2.0M | $364,766 |
Total Patients
18,499
Total Services
28,773
Medicare Billing
$1.3M
Procedure Codes
165
All Medicare Procedures & Services
165 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 759 | 1,343 | $264,571 | $105,915 | 40.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 705 | 726 | $603,306 | $33,985 | 5.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 60 | 63 | $44,919 | $12,846 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 115 | 115 | $33,235 | $11,711 | 35.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 107 | 110 | $26,730 | $10,325 | 38.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 78 | 161 | $20,125 | $9,348 | 46.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 172 | 172 | $43,616 | $9,109 | 20.9% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 20 | 20 | $46,060 | $7,422 | 16.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 57 | 114 | $8,436 | $4,210 | 49.9% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 56 | 160 | $5,956 | $3,574 | 60.0% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $23,964 | $3,242 | 13.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 49 | 105 | $3,465 | $2,133 | 61.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 68 | 148 | $3,848 | $2,085 | 54.2% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 34 | 117 | $3,276 | $2,033 | 62.1% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $5,521 | $1,983 | 35.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 23 | 25 | $14,350 | $1,917 | 13.4% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 32 | 109 | $3,052 | $1,888 | 61.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 177 | 177 | $8,673 | $1,789 | 20.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 46 | 70 | $9,380 | $1,746 | 18.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 76 | 87 | $18,618 | $1,607 | 8.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 141 | 153 | $28,917 | $1,409 | 4.9% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 19 | 43 | $9,675 | $1,120 | 11.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 109 | 113 | $5,989 | $1,065 | 17.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 20 | 223 | $4,237 | $936.60 | 22.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 45 | 45 | $2,430 | $845.55 | 34.8% |
About Dr. Julius Kato, DO
Dr. Julius Kato, DO is a Cardiovascular Disease healthcare provider based in Lima, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124098819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Julius Kato, DO has received a total of $6,058 in payments from pharmaceutical and medical device companies, with $739.23 received in 2024. These payments were reported across 279 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,662).
As a Medicare-enrolled provider, Kato has provided services to 18,499 Medicare beneficiaries, totaling 28,773 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 165 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Lima, OH
- Active Since 01/25/2006
- Last Updated 03/17/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1124098819
Products in Payments
- GENERAL THERAPIES (Device) $1,373
- LifeVest (Device) $388.93
- Resolute (Device) $323.40
- ENTRESTO (Drug) $281.26
- XARELTO (Drug) $207.00
- Impella (Device) $204.58
- BRILINTA (Drug) $187.20
- ONYX FRONTIER (Device) $178.69
- CoreValve Evolut (Device) $163.67
- CardioMEMS HF System (Device) $156.87
- CARDIOMEMS (Device) $146.85
- PRALUENT (Biological) $109.03
- MITRACLIP (Device) $104.52
- LEQVIO (Drug) $85.68
- FARXIGA (Drug) $85.65
- IGT D Coronary (Device) $77.33
- HawkOne (Device) $76.90
- Repatha (Biological) $75.69
- CardioInsight (Device) $74.05
- SYMPLICITY G3 (Device) $73.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lima
Dr. Pamela Gardner, Do, DO
Cardiovascular Disease — Payments: $24,123
Cardiovascular Disease $24,123
Masroor Abro, M.d, M.D
Cardiovascular Disease — Payments: $14,304
Cardiovascular Disease $14,304
Dr. Paul Anike, Do, DO
Cardiovascular Disease — Payments: $12,788
Cardiovascular Disease $12,788
Dr. Venkat Battula, Md, MD
Cardiovascular Disease — Payments: $11,418
Cardiovascular Disease $11,418
Adel Shaheen, Md, MD
Cardiovascular Disease — Payments: $8,259
Cardiovascular Disease $8,259
Dr. Mehran Arabpour, Do, DO
Cardiovascular Disease — Payments: $7,110
Cardiovascular Disease $7,110